EYPT
EyePoint Pharmaceuticals, Inc.$13.45-0.15 (-1.10%)Prev Close$13.60·MCap$1.15B·P/E—·Vol352.7K·Yield—
▲
Buys (12M)
3
$133.2K
▼
Sells (12M)
7
$1.93M
◆
Net Activity
Net Seller
$1.79M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at EyePoint Pharmaceuticals, Inc. (EYPT) has been dominated by selling, with 3 insider purchases totaling $133.2K and 7 insider sales totaling $1.93M. The most recent insider transaction was by Ribeiro Ramiro (officer: Chief Medical Officer), who sold $36.6K worth of shares on Apr 20, 2026. EyePoint Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.15B.
EYPT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Ribeiro Ramiro | officer: Chief Medical Officer | Sell | 2,437 | $15.00 | $36.6K | 0Exit |
| Mar 16, 2026 | Duker Jay S. | director, officer: President and CEO | Buy | 1,500 | $13.15 | $19.7K | 100,665 |
| Feb 17, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell | 2,437 | $15.00 | $36.6K | 0 |
| Jan 7, 2026 | Ribeiro Ramiro | officer: Chief Medical Officer | Sell | 42,544 | $17.10 | $727.3K | 0Exit |
| Dec 8, 2025 | Cormorant Asset Management, LP | Sell | 60,000 | $15.70 | $942.2K | 8,265,000 | |
| Dec 5, 2025 | Lurker Nancy | Sell | 9,300 | $15.11 | $140.5K | 206,547 | |
| Dec 1, 2025 | Lurker Nancy | Sell | 700 | $14.95 | $10.5K | 216,347 | |
| Nov 12, 2025 | Ribeiro Ramiro | Chief Medical Officer | Sell | 2,722 | $11.61 | $31.6K | 0Exit |
| May 19, 2025 | Zaderej Karen L. | Buy | 10,000 | $5.90 | $59.0K | 36,500+38% | |
| May 15, 2025 | Zaderej Karen L. | Buy | 10,000 | $5.45 | $54.5K | 26,500+61% | |
| Aug 21, 2024 | ANDO GORAN | Buy | 5,000 | $7.95 | $39.8K | 13,150+61% | |
| Aug 21, 2024 | DICICCO WENDY F | Buy | 2,567 | $7.79 | $20.0K | 9,967+35% | |
| Aug 21, 2024 | Zaderej Karen L. | Buy | 12,500 | $7.98 | $99.8K | 16,500+313% | |
| Aug 20, 2024 | Lurker Nancy | Buy | 3,173 | $7.88 | $25.0K | 97,635 | |
| Jul 16, 2024 | GUYER DAVID R | Sell | 11,625 | $10.06 | $117.0K | 1,850-86% | |
| Jun 4, 2024 | GUYER DAVID R | Sell | 11,625 | $10.30 | $119.7K | 3,700-76% | |
| May 16, 2024 | GUYER DAVID R | Sell | 11,625 | $12.65 | $147.0K | 5,550-68% | |
| May 8, 2024 | Cormorant Asset Management, LP | Buy | 850,000 | $11.86 | $10.08M1.0% OS | 8,325,000 | |
| Apr 22, 2024 | Cormorant Asset Management, LP | Buy | 581,765 | $18.03 | $10.49M0.7% OS | 7,475,000 | |
| Feb 5, 2024 | Jones David Scott | SVP & Chief Commercial Officer | Sell | 209 | $28.49 | $6.0K | 37,962 |
| Jan 30, 2024 | Paggiarino Dario A. | Chief Medical Officer | Sell | 49,325 | $25.66 | $1.27M | 85,779-37% |
| Jan 29, 2024 | Jones David Scott | SVP & Chief Commercial Officer | Sell | 26,017 | $25.38 | $660.4K | 47,566-35% |
| Jan 29, 2024 | Paggiarino Dario A. | Chief Medical Officer | Sell | 600 | $25.00 | $15.0K | 36,805 |
| Jan 26, 2024 | Jones David Scott | SVP & Chief Commercial Officer | Sell | 11,900 | $25.01 | $297.6K | 43,562 |
| Jan 25, 2024 | Lurker Nancy | Executive Vice Chair | Sell | 35,000 | $24.98 | $874.2K | 165,397 |
| Jan 25, 2024 | Paggiarino Dario A. | Chief Medical Officer | Sell | 16,386 | $25.01 | $409.8K | 42,156-28% |
| Jan 24, 2024 | Jones David Scott | SVP & Chief Commercial Officer | Sell | 35,066 | $22.68 | $795.2K | 66,712-34% |
| Jan 16, 2024 | Ocumension Therapeutics | Director | Sell | 1,910,500 | $19.45 | $37.16M2.3% OS | 100,221-95% |
| Jan 11, 2024 | Cormorant Asset Management, LP | Buy | 855,000 | $19.94 | $17.05M1.0% OS | 6,893,235 | |
| Jan 10, 2024 | Paggiarino Dario A. | Chief Medical Officer | Sell | 22,913 | $21.13 | $484.1K | 36,505-39% |
| Dec 15, 2023 | Paggiarino Dario A. | Chief Medical Officer | Sell | 1,458 | $20.00 | $29.2K | 25,707 |
| Dec 12, 2023 | Cormorant Asset Management, LP | Buy | 588,235 | $17.00 | $10.00M0.7% OS | 6,038,235 | |
| Dec 7, 2023 | Ocumension Therapeutics | Director | Sell | 1,000,000 | $19.51 | $19.51M1.2% OS | 2,276,963-31% |
| Dec 6, 2023 | Cormorant Asset Management, LP | Buy | 1,919,057 | $21.82 | $41.87M2.3% OS | 5,450,000+54% | |
| Dec 6, 2023 | Lurker Nancy | Executive Vice Chair | Sell | 20,000 | $20.76 | $415.2K | 170,559 |
| Dec 6, 2023 | Paggiarino Dario A. | Chief Medical Officer | Sell | 30,625 | $22.00 | $673.8K | 25,707-54% |
| Dec 6, 2023 | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Sell | 45,000 | $22.00 | $990.0K | 5,343-89% |
| Sep 6, 2023 | EW Healthcare Partners, L.P. | 10% Owner | Sell | 20,000 | $9.90 | $198.0K | 3,490,921 |
| Sep 1, 2023 | EW Healthcare Partners, L.P. | 10% Owner | Sell | 139,471 | $10.54 | $1.47M | 3,589,743 |
| Aug 30, 2023 | EW Healthcare Partners, L.P. | 10% Owner | Sell | 148,712 | $11.14 | $1.66M | 3,738,246 |
| Aug 28, 2023 | EW Healthcare Partners, L.P. | Sell | 223,936 | $13.25 | $2.97M | 3,883,760 | |
| Aug 24, 2023 | EW Healthcare Partners, L.P. | 10% Owner | Sell | 167,881 | $13.49 | $2.26M | 4,144,143 |
| May 31, 2023 | Liu Ye | Sell | 1 | $6.00 | $6.00 | 3,010,721 | |
| Mar 15, 2022 | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Buy | 1,000 | $12.21 | $12.2K | 1,000 |
| Nov 17, 2021 | Lurker Nancy | President & CEO | Sell | 10,000 | $20.15 | $201.5K | 103,546 |
EYPT Insider Buying Activity
The following table shows recent insider purchases of EyePoint Pharmaceuticals, Inc. (EYPT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Duker Jay S. | director, officer: President and CEO | Buy | 1,500 | $13.15 | $19.7K | 100,665 |
| May 19, 2025 | Zaderej Karen L. | Buy | 10,000 | $5.90 | $59.0K | 36,500+38% | |
| May 15, 2025 | Zaderej Karen L. | Buy | 10,000 | $5.45 | $54.5K | 26,500+61% | |
| Aug 21, 2024 | ANDO GORAN | Buy | 5,000 | $7.95 | $39.8K | 13,150+61% | |
| Aug 21, 2024 | DICICCO WENDY F | Buy | 2,567 | $7.79 | $20.0K | 9,967+35% | |
| Aug 21, 2024 | Zaderej Karen L. | Buy | 12,500 | $7.98 | $99.8K | 16,500+313% | |
| Aug 20, 2024 | Lurker Nancy | Buy | 3,173 | $7.88 | $25.0K | 97,635 | |
| May 8, 2024 | Cormorant Asset Management, LP | Buy | 850,000 | $11.86 | $10.08M1.0% OS | 8,325,000 | |
| Apr 22, 2024 | Cormorant Asset Management, LP | Buy | 581,765 | $18.03 | $10.49M0.7% OS | 7,475,000 | |
| Jan 11, 2024 | Cormorant Asset Management, LP | Buy | 855,000 | $19.94 | $17.05M1.0% OS | 6,893,235 | |
| Dec 12, 2023 | Cormorant Asset Management, LP | Buy | 588,235 | $17.00 | $10.00M0.7% OS | 6,038,235 | |
| Dec 6, 2023 | Cormorant Asset Management, LP | Buy | 1,919,057 | $21.82 | $41.87M2.3% OS | 5,450,000+54% | |
| Mar 15, 2022 | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Buy | 1,000 | $12.21 | $12.2K | 1,000 |
EYPT Insider Selling Activity
The following table shows recent insider sales of EyePoint Pharmaceuticals, Inc. (EYPT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Ribeiro Ramiro | officer: Chief Medical Officer | Sell | 2,437 | $15.00 | $36.6K | 0Exit |
| Feb 17, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell | 2,437 | $15.00 | $36.6K | 0 |
| Jan 7, 2026 | Ribeiro Ramiro | officer: Chief Medical Officer | Sell | 42,544 | $17.10 | $727.3K | 0Exit |
| Dec 8, 2025 | Cormorant Asset Management, LP | Sell | 60,000 | $15.70 | $942.2K | 8,265,000 | |
| Dec 5, 2025 | Lurker Nancy | Sell | 9,300 | $15.11 | $140.5K | 206,547 | |
| Dec 1, 2025 | Lurker Nancy | Sell | 700 | $14.95 | $10.5K | 216,347 | |
| Nov 12, 2025 | Ribeiro Ramiro | Chief Medical Officer | Sell | 2,722 | $11.61 | $31.6K | 0Exit |
| Jul 16, 2024 | GUYER DAVID R | Sell | 11,625 | $10.06 | $117.0K | 1,850-86% | |
| Jun 4, 2024 | GUYER DAVID R | Sell | 11,625 | $10.30 | $119.7K | 3,700-76% | |
| May 16, 2024 | GUYER DAVID R | Sell | 11,625 | $12.65 | $147.0K | 5,550-68% | |
| Feb 5, 2024 | Jones David Scott | SVP & Chief Commercial Officer | Sell | 209 | $28.49 | $6.0K | 37,962 |
| Jan 30, 2024 | Paggiarino Dario A. | Chief Medical Officer | Sell | 49,325 | $25.66 | $1.27M | 85,779-37% |
| Jan 29, 2024 | Jones David Scott | SVP & Chief Commercial Officer | Sell | 26,017 | $25.38 | $660.4K | 47,566-35% |
| Jan 29, 2024 | Paggiarino Dario A. | Chief Medical Officer | Sell | 600 | $25.00 | $15.0K | 36,805 |
| Jan 26, 2024 | Jones David Scott | SVP & Chief Commercial Officer | Sell | 11,900 | $25.01 | $297.6K | 43,562 |
| Jan 25, 2024 | Lurker Nancy | Executive Vice Chair | Sell | 35,000 | $24.98 | $874.2K | 165,397 |
| Jan 25, 2024 | Paggiarino Dario A. | Chief Medical Officer | Sell | 16,386 | $25.01 | $409.8K | 42,156-28% |
| Jan 24, 2024 | Jones David Scott | SVP & Chief Commercial Officer | Sell | 35,066 | $22.68 | $795.2K | 66,712-34% |
| Jan 16, 2024 | Ocumension Therapeutics | Director | Sell | 1,910,500 | $19.45 | $37.16M2.3% OS | 100,221-95% |
| Jan 10, 2024 | Paggiarino Dario A. | Chief Medical Officer | Sell | 22,913 | $21.13 | $484.1K | 36,505-39% |
| Dec 15, 2023 | Paggiarino Dario A. | Chief Medical Officer | Sell | 1,458 | $20.00 | $29.2K | 25,707 |
| Dec 7, 2023 | Ocumension Therapeutics | Director | Sell | 1,000,000 | $19.51 | $19.51M1.2% OS | 2,276,963-31% |
| Dec 6, 2023 | Lurker Nancy | Executive Vice Chair | Sell | 20,000 | $20.76 | $415.2K | 170,559 |
| Dec 6, 2023 | Paggiarino Dario A. | Chief Medical Officer | Sell | 30,625 | $22.00 | $673.8K | 25,707-54% |
| Dec 6, 2023 | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Sell | 45,000 | $22.00 | $990.0K | 5,343-89% |
| Sep 6, 2023 | EW Healthcare Partners, L.P. | 10% Owner | Sell | 20,000 | $9.90 | $198.0K | 3,490,921 |
| Sep 1, 2023 | EW Healthcare Partners, L.P. | 10% Owner | Sell | 139,471 | $10.54 | $1.47M | 3,589,743 |
| Aug 30, 2023 | EW Healthcare Partners, L.P. | 10% Owner | Sell | 148,712 | $11.14 | $1.66M | 3,738,246 |
| Aug 28, 2023 | EW Healthcare Partners, L.P. | Sell | 223,936 | $13.25 | $2.97M | 3,883,760 | |
| Aug 24, 2023 | EW Healthcare Partners, L.P. | 10% Owner | Sell | 167,881 | $13.49 | $2.26M | 4,144,143 |
| May 31, 2023 | Liu Ye | Sell | 1 | $6.00 | $6.00 | 3,010,721 | |
| Nov 17, 2021 | Lurker Nancy | President & CEO | Sell | 10,000 | $20.15 | $201.5K | 103,546 |
EYPT Insiders
Similar Stocks to EYPT
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B